<?xml version="1.0" encoding="UTF-8"?>
<p>Summarizing, numerous vitamin D clinical trials for COVID-19 could be useful to determine its effect on disease progression and post-exposure prophylaxis. One idea is that its supplementation can help patients to maintain sufficient serum levels of vitamin D as recommended by guidelines [
 <xref rid="B160-molecules-26-00632" ref-type="bibr">160</xref>]. The known potential of vitamin D modulating the innate immune response may be auspicious to prevent acute respiratory infection [
 <xref rid="B161-molecules-26-00632" ref-type="bibr">161</xref>]. Based on the knowledge that COVID-19 disproportionately affects race, ethnicity, minority groups, and the known vitamin D deficiency in the same groups, the use of natural derivatives may provide a chance for decreasing health disparities [
 <xref rid="B162-molecules-26-00632" ref-type="bibr">162</xref>].
</p>
